The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Ultimately, AI and its impacts will transcend national borders. But the infrastructure that underpins it will remain firmly ...